Industry Newsgenetic targetscardiovasculartenaya therapeuticsalnylam pharmaceuticals
Tenaya Therapeutics Enters Collaboration With Alnylam To Identify Targets
4.9
Relevance Score
Tenaya Therapeutics and Alnylam Pharmaceuticals enter a research collaboration to identify and validate novel genetic targets for cardiovascular disease therapeutics. The agreement combines Tenaya’s expertise in identification and validation, according to the RSS description.
